Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2024-03-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a decision to issue new shares through a third-party allocation (유상증자결정). This document details the purpose of the capital increase, the number of shares, the pricing methodology, and the target entity (MicroX). This falls under the category of share issuance and capital changes.
2024-03-28 Korean
소액공모공시서류(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Small-Scale Public Offering Disclosure Document' (소액공모공시서류) filed by Anygen Co., Ltd. with the Financial Supervisory Service (FSS) in South Korea. It details a third-party allocation capital increase (유상증자) of 66,093 shares. This type of filing is a specific regulatory requirement for offerings under 1 billion KRW that do not require a full securities registration statement. Among the provided categories, this fits best as a 'Regulatory Filing' (RNS) as it is a formal disclosure document submitted to a regulatory body regarding a capital change that does not fit into the more specific categories like 'Share Issue/Capital Change' (SHA) which is typically for larger public offerings or general announcements, or 'Capital/Financing Update' (CAP). Given the specific nature of the Korean 'Small-Scale Public Offering' (소액공모), RNS is the most appropriate fallback.
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company AnyGen. It provides the audit opinion, key financial data, and details regarding capital impairment and operating losses as required by regulatory standards. While it contains financial data, it is a formal notification of the audit report's submission rather than the full annual report (10-K) or a standalone audit report document. Given the short length and the nature of the filing as a regulatory disclosure of the audit results, it fits the 'Audit Report / Information' category. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Anygen Co., Ltd. for the fiscal year 2023 (Jan 1, 2023 - Dec 31, 2023). It contains comprehensive company information, including management details, capital changes, articles of incorporation, and business descriptions. This is a standard annual regulatory filing in South Korea, which corresponds to the '10-K' category in the provided schema as it represents the official yearly report covering company activity and financial performance. FY 2023
2024-03-20 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains specific agenda items such as approval of financial statements, amendments to the articles of incorporation, and director/auditor compensation limits. This falls under the category of Proxy Solicitation & Information Statement (PSI).
2024-03-14 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company Anygen. It outlines the date, time, location, and the agenda items (such as approval of financial statements, amendments to articles of incorporation, and director remuneration). This document serves as the official notification to shareholders regarding an upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to exercise their voting rights.
2024-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.